Is sputum eosinophila a good or poor predictor of benefit from inhaled corticosteroid therapy in asthma?

European Respiratory Journal

Volumn 20, Issue 6, 2002, Pages 1359-1361

  Pizzichini, M M M ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; PREDNISOLONE; STEROID;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; EDITORIAL; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; HUMAN; OUTCOMES RESEARCH; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPUTUM CYTODIAGNOSIS; SYMPTOMATOLOGY; CYTOLOGY; INHALATIONAL DRUG ADMINISTRATION; NOTE; SPUTUM;

ADMINISTRATION, INHALATION; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; EOSINOPHILIA; HUMANS; SPUTUM; STEROIDS;

EID: 0036882345     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.00068102     Document Type: Editorial

References (29)

1. Gollash A. Zue des asthatischen sputums. Fortschr Med (Berlin) 1989; 7: 361-365.
2. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Int Med 1922; 30: 689-760.
3. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002; 57: 643-648.
4. Turner MO, Hussack P, Sears MR, Dolovich J, Hargreave FE. Exacerbations of asthma without sputum eosinophilia. Thorax 1995; 50: 1057-1061.
5. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95: 843 -852.
6. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
7. Wenzel ES, Szefler S, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose of glucocorticoids. Am J Respir Crit Care Med 1997; 156: 737-743.
8. Stevenson EC, Turner G, Heaney LG, et al. Broncho-alveolar lavage findings suggest two different forms of childhood asthma. Clin Exper Allergy 1997; 27: 1027-1035.
9. Pizzichini MMM, Pizzichini E, Efthimiadis A, et al. Asthma and natural colds: inflammatory indices in induced sputum. A feasibility study. Am J Respir Crit Care Med 1998; 158: 1178-1184.
10. Pavord ID, Brightling CE, Wolkman G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353: 2213-2214.
11. Jatanakon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160: 1532-1539.
12. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: Evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001; 119: 1329-1336.
13. Chalmers GW, MacLeod KJ, Thomson L, et al. Smoking and airway inflammation in patients with mild asthma. Chest 2001; 120: 1917-1922.
14. Gauvreau GM, Watson RM, O'Byrne PM. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. Am J Respir Crit Care Med 1999; 160: 640-647.
15. Nightingale JA, Rogers DF, Barnes PJ. Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects. Thorax 1999; 54: 1061-1069.
16. Nordenhall C, Pourazar J, Blomberg A, Levin JO, Sandstrom T, Adelroth E. Airway inflammation following exposure to diesel exhaust: a study of time kinetics using induced sputum. Eur Respir J 2000; 15: 1046-1051.
17. Parameswaran K, Pizzichini E, Pizzichini MMM, Hussack P, Efthimiadis A, Hargreave FE. Cinical judgement of airway inflammation versus sputum cell counts in patients with asthma. Eur Respir J 2000; 15: 486-490.
18. Mamstrom K, Rodriguez-Gomes G, Guerra J, et al. Oral montelukast, inhaled beclomethasone and placebo for chronic asthma. A randomised controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999; 130: 487-495.
19. Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroid for persistent asthma. J Allergy Clin Immunol 2002; 109: 410-418.
20. Godon P, Boulet L-P, Malo J-L, Cartier A, Lemiere C. Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids. Eur Respir J 2002; 20: 1364-1369.
21. Brown HM. Treatment of chronic asthma with prednisolone: significance of eosinophils in sputum. Lancet 1958; ii: 1245-1247.
22. Little SA, Chalmers GW, MacLeod KJ, McScharry C, Thomson NC. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000; 55: 232-234.
23. Meijer RJ, Postma DS, Kauffman LR, Koëter GH, Kerstjens HAM. Accuracy ofeosinophils and eosinophil cationic protein to predict steroid improvement in asthma. Clin Exper Allergy 2002; 32: 1096-1113.
24. Juniper EF, Guyatt GH, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832-838.
25. Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993; 148: 675-681.
26. Pizzichini MMM, Kidney JC, Wong BJO, et al. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Eur Respir J 1996; 9: 449-455.
27. Turner MO, Johnston P, Pizzichini E, Pizzichini MMM, Hargreave FE. Anti-inflammatory effects of salmeterol compared with beclomethasone in mildly uncontrolled asthma: A randomized placebo controlled trial. Can Respir J 1998; 5: 261-268.
28. McIvor RA, Pizzichini E, Turner MO, Hussack P, Hargreave FE, Sears MR. Steroid-sparing versus masking effects of adding salmeterol to high dose inhaled corticosteroid treatment of asthma. Am J Respir Crit Care Med 1998; 158: 924-930.
29. Green RH, Brightling CE, MacKenna S, Parker D, Wardlaw AJ, Pavord ID. Reduced asthma exacerbations with a management strategy directed at normalizing the sputum eosinophil count. Am J Respir Care Med 2002; 165: A320.